Share the post "IPO Launch: Senores Pharmaceuticals’s Initial public offering on 20-12-2024!"
An Initial Public Offering (IPO) is the launch of a company’s shares on the public market, making it accessible to individual and institutional investors. This process transforms a private entity into a publicly traded company, allowing it to raise capital for various initiatives, such as expansion or innovation. The IPO journey involves careful planning, regulatory compliance, and strategic marketing to ensure successful entry into the stock market. Senores Pharmaceuticals IPO of Initial public offering type offers an equity issue (inclusive of premium) with a face value of ₹ 10.00. The issue is live from 20 Dec 2024 to 24 Dec 2024 , with a market lot of 38 shares. This call notice includes , covering ₹10.00 towards face value and the remaining towards securities premium. This is a chance to invest in a well-established company known for its quality and innovation.
| Security Name | Senores Pharmaceuticals Limited |
|---|---|
| Offer Price () | 372.00 – 391.00 |
| Face Value | 10.00 |
| Type Of Issue | IPO |
| Issue Status | Forthcoming |
| Security Type | Equity |
| Symbol | SENORES |
| Issue Period | 20 Dec 2024 to 24 Dec 2024 |
| IPO Market Timings | 10.00 a.m. to 5.00 p.m. |
| Cut-off Time For UPI Mandate Confirmation | 24-Dec-2024 (Upto 5.00 pm) |
| Issue Size – No. Of Shares | 1,55,40,860 |
| Price Band | 372.00-391.00 |
| Tick Size | 1.00 |
| Market Lot | 38 |
| Minimum Bid Quantity | 38 |
| Maximum Bid Quantity For Qualified Institutional Investors | 15540860 |
| Maximum Bid Quantity For Non-Institutional Investors | 3941436 |
| Book Running Lead Manager | Nuvama Wealth ManagementLimited |
| Co-Book Running Lead Manager | 1) Ambit Private Limited2) Equirus Capital Private Limited |
| Registrar | Link Intime India Private Limited |
| Sponsor Bank | 1) HDFC BANK2) ICICI BANK |
| Exchange Notices | 1) Processing of ASBA applications in Public Issue of Equity Shares and Convertibles |
| Notes | As per SEBI circular no SEBI/HO/CFD/DIL2/CIR/P/2019/76 dated 28 June 28 2019 all are requested to comply with the provisions of the aforementioned circular which states as below: Intermediaries shall retain physical application forms submitted by retail individual investors with UPI as a payment mechanism, for a period of six months and thereafter forward the same to the issuer/ Registrar to Issue. However, in case of electronic forms printouts of such applications need not be retained or sent to the issuer. Intermediaries shall at all times maintain the electronic records relating to such forms for a minimum period of three years. |
| Remarks | Categories applicable for UPI : IND and EMP (upto Rs.5 Lakhs) |
Senores Pharmaceuticals IPO opens on 20-12-2024, and closes on 24-12-2024
| Start Date | 20-12-2024 |
|---|---|
| End Date | 24-12-2024 |
| Issue Period | 20 Dec 2024 to 24 Dec 2024 |
Here are more informative data links:
- Price-Band Advertisement
- Prospectus & GID
- Blank ASBA Form
- Online ASBA Form
- Revised Online ASBA Form
- Registrars To An Issue And Share Transfer Agents/Depository Participants
- Branches Of SCSBs Where Syndicate / Sub Syndicate Member To Submit ASBA Form
- List Of SCSBs For Syndicate ASBA And Under ASBA Facility
- Self Certified Syndicate Banks Eligible As Issuer Banks For UPI
